Zobrazeno 1 - 10
of 244
pro vyhledávání: '"David L, Swerdlow"'
Autor:
Marc Lipsitch, Mary T. Bassett, John S. Brownstein, Paul Elliott, David Eyre, M. Kate Grabowski, James A. Hay, Michael A. Johansson, Stephen M. Kissler, Daniel B. Larremore, Jennifer E. Layden, Justin Lessler, Ruth Lynfield, Duncan MacCannell, Lawrence C. Madoff, C. Jessica E. Metcalf, Lauren A. Meyers, Sylvia K. Ofori, Celia Quinn, Ana I. Bento, Nicholas G. Reich, Steven Riley, Roni Rosenfeld, Matthew H. Samore, Rangarajan Sampath, Rachel B. Slayton, David L. Swerdlow, Shaun Truelove, Jay K. Varma, Yonatan H. Grad
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
The COVID-19 pandemic has highlighted the need to upgrade systems for infectious disease surveillance and forecasting and modeling of the spread of infection, both of which inform evidence-based public health guidance and policies. Here, we discuss r
Externí odkaz:
https://doaj.org/article/b1e49f1194724dada8d5715b590e7109
Autor:
Teresa K. Yamana, Marta Galanti, Sen Pei, Manuela Di Fusco, Frederick J. Angulo, Mary M. Moran, Farid Khan, David L. Swerdlow, Jeffrey Shaman
Publikováno v:
PLoS ONE, Vol 18, Iss 4 (2023)
By August 1, 2022, the SARS-CoV-2 virus had caused over 90 million cases of COVID-19 and one million deaths in the United States. Since December 2020, SARS-CoV-2 vaccines have been a key component of US pandemic response; however, the impacts of vacc
Externí odkaz:
https://doaj.org/article/e6b38ab3378c462e98efa2900ec8f5e8
Autor:
Jay Love, Lindsay T. Keegan, Frederick J. Angulo, John M. McLaughlin, Kimberly M. Shea, David L. Swerdlow, Matthew H. Samore, Damon J. A. Toth
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-5 (2021)
Abstract Long-term care facilities (LTCFs) bear disproportionate burden of COVID-19 and are prioritized for vaccine deployment. LTCF outbreaks could continue occurring during vaccine rollout due to incomplete population coverage, and the effect of va
Externí odkaz:
https://doaj.org/article/a24a16603d7f4622b0b37fba0f0d1d0c
Autor:
Myint Tin Tin Htar, Sally Jackson, Paul Balmer, Lidia Cristina Serra, Andrew Vyse, Mary Slack, Margarita Riera-Montes, David L. Swerdlow, Jamie Findlow
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Monovalent meningococcal C conjugate vaccine (MCCV) was introduced into the routine immunization program in many countries in Europe and worldwide following the emergence of meningococcal serogroup C (MenC) in the late 1990s. This
Externí odkaz:
https://doaj.org/article/f10550c29f1f4c9989fe1bc2c6c4e7ff
Publikováno v:
The Lancet Regional Health. Americas, Vol 9, Iss , Pp 100191- (2022)
Summary: Background: On Dec 14, 2020, the United States initiated a nationwide COVID-19 vaccination campaign. Demonstrating clear population-level impact following vaccine introduction helps to further elucidate and quantify the public-health benefit
Externí odkaz:
https://doaj.org/article/370b1eca7356480482ffdf75bdba84cf
Autor:
Jennifer L Nguyen, Michael Benigno, Deepa Malhotra, Farid Khan, Frederick J Angulo, Jennifer Hammond, David L Swerdlow, Maya Reimbaeva, Birol Emir, John M McLaughlin
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262347 (2022)
BackgroundThe COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has substantially impacted healthcare utilization worldwide. The objective of this retrospective analysis of a large hospital discharge
Externí odkaz:
https://doaj.org/article/6fe254989ab44206a74a0f787a0bf4b4
Autor:
Shepherd R. Singer, M.D., Frederick J. Angulo, Ph.D., David L. Swerdlow, M.D., John M. McLaughlin, Ph.D., Itay Hazan, M.Sc., Netanel Ginish, B.S, Emilia Anis, M.D., Ella Mendelson, Ph.D., Orna Mor, Ph.D., Neta S Zuckerman, Ph.D., Oran Erster, Ph.D., Jo Southern, Ph.D., Kaijie Pan, M.S., Gabriel Mircus, Ph.D., Marc Lipsitch, D.Phil., Eric J. Haas, M.D., Luis Jodar, Ph.D., Yeheskel Levy, M.D., Sharon Alroy-Preis, M.D.
Publikováno v:
EClinicalMedicine, Vol 42, Iss , Pp 101190- (2021)
Background: SARS-CoV-2 variant Beta (B.1.351) was designated as a Variant of Concern (VoC) after becoming the dominant strain in South Africa and spreading internationally. BNT162b2 showed lower levels of neutralizing antibodies against Beta than aga
Externí odkaz:
https://doaj.org/article/62a9342b69cb4e34bc3842674ef15451
Autor:
John M. McLaughlin, David L. Swerdlow, Farid Khan, Oliver Will, Aaron Curry, Vincenza Snow, Raul E. Isturiz, Luis Jodar
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 841-849 (2019)
Background: In September 2014, 13-valent pneumococcal conjugate vaccine (PCV13) was universally recommended for all US adults aged ≥65 years. Adult PCV13 coverage, including whether disparities in uptake exist, however, is not well-described. Metho
Externí odkaz:
https://doaj.org/article/81e189dc97c64eb6b52bdf6b21650442
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 584-593 (2019)
Thirteen-valent pneumococcal conjugate vaccine (PCV13) was licensed in adults to address the unmet medical need of vaccine-type community acquired pneumonia (CAP) and the limitations of previous plain-polysaccharide vaccines. Since then, some have qu
Externí odkaz:
https://doaj.org/article/8394bcf840114badaf12e310185827ab
Autor:
Christian Lenz, Mary P.E Slack, Kimberly M. Shea, Ralf René Reinert, Bülent N. Taysi, David L. Swerdlow
Publikováno v:
Critical Reviews in Microbiology. :1-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a51702ccea06dacbb42cb6c979fd5ce
https://doi.org/10.1080/1040841x.2023.2190405
https://doi.org/10.1080/1040841x.2023.2190405